B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies is a paper indexed in PICO Portal from OpenAlex.
How many citations does B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies have?
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies has 204 citations in the OpenAlex counts PICO Portal stores.
When was B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies published?
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies has 2013 year in the PICO Portal index.
What is the open-access status of B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies?
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies has gold oa status in the PICO Portal index.
What is the DOI of B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies?
The DOI for B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies is on the source record.
What is the PMID of B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies?
The PMID for B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies is on the source record.
What is the OpenAlex record for B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies?
The OpenAlex for B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies is on the source record.